3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
5
Small Cell Lung Carcinoma
2
Non-squamous Non-small Cell Lung Cancer
2
Breast Neoplasms
2
Vulvar Neoplasms
1
Uterine Cervical Neoplasms
1
Sertoli-Leydig Cell Tumor
1
Ovarian gynandroblastoma
1
Ovarian Neoplasms
1
Non-squamous NSCLC
1
Lung Neoplasms
1
Locally Advanced Cervical Carcinoma
1
Hypopharyngeal Neoplasms
1
Head and Neck Neoplasms
1
Granulosa cell tumor of the ovary
1
Gastrointestinal Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation
1
Endometrial Clear Cell Adenocarcinoma
1
Brain Neoplasms
1
Anus Neoplasms
1
Anal Canal Carcinoma
1
Advanced Esophagus Cancer
1
Interventions
dehydroftorafur
1
Taxes
1
Radiotherapy, Intensity-Modulated
1
Radiation
1
Platinum
1
Paclitaxel
1
Immune Checkpoint Inhibitors
1
Fluorouracil
1
Cisplatin
1
Chemoradiotherapy
1
Carboplatin
1
Capecitabine
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Anal Canal Carcinoma
×
Platinum
×
Clear all
NCT02560298
2023-06-22
InterAACT
Eastern Cooperative Oncology Group
Phase 2
Unknown
91 enrolled